Loomis Sayles & Co. L P Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Loomis Sayles & Co. L P lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,783,323 shares of the medical equipment provider's stock after selling 49,268 shares during the quarter. Intuitive Surgical accounts for about 1.2% of Loomis Sayles & Co. L P's holdings, making the stock its 21st biggest position. Loomis Sayles & Co. L P owned approximately 0.50% of Intuitive Surgical worth $876,093,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Harvest Fund Management Co. Ltd increased its holdings in shares of Intuitive Surgical by 32.9% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 23,154 shares of the medical equipment provider's stock valued at $11,372,000 after purchasing an additional 5,729 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Intuitive Surgical during the third quarter worth about $559,000. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock worth $2,349,441,000 after buying an additional 86,208 shares during the period. Daiwa Securities Group Inc. increased its holdings in Intuitive Surgical by 13.5% in the third quarter. Daiwa Securities Group Inc. now owns 86,257 shares of the medical equipment provider's stock valued at $42,375,000 after buying an additional 10,267 shares in the last quarter. Finally, Marco Investment Management LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $264,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on ISRG shares. Piper Sandler reaffirmed an "overweight" rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. Redburn Atlantic raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and upped their price target for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $524.61.

Intuitive Surgical Price Performance

ISRG stock traded down $11.32 on Monday, hitting $536.55. 2,067,732 shares of the company were exchanged, compared to its average volume of 1,458,954. The stock has a market capitalization of $191.11 billion, a price-to-earnings ratio of 88.08, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00. The business's fifty day moving average is $504.73 and its two-hundred day moving average is $464.13.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the business's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now owns 1,595 shares in the company, valued at $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 450 shares of the company's stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares of the company's stock, valued at $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,539 shares of company stock worth $26,112,364 over the last three months. 0.80% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.